Page last updated: 2024-08-24

aripiprazole and Dementia, Vascular

aripiprazole has been researched along with Dementia, Vascular in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heo, HJ; Hong, KW; Kim, CD; Kim, HY; Lee, WS; Lee, YS; Park, SY; Shin, HK	1
Cretaz, E; Diniz, BS; Forlenza, OV	1
Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Rappaport, SA	1

Reviews

1 review(s) available for aripiprazole and Dementia, Vascular

Article	Year
[The use of antipsychotics in patients with dementia]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome	2008

Article

Year

[The use of antipsychotics in patients with dementia].

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3

Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome

2008

Trials

1 trial(s) available for aripiprazole and Dementia, Vascular

Article	Year
A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dementia, Vascular; Double-Blind Method; Drug Tolerance; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Placebos; Psychomotor Agitation; Quinolones; United States	2009

Article

Year

A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia.

Journal of the American Medical Directors Association, 2009, Volume: 10, Issue:1

Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Dementia, Vascular; Double-Blind Method; Drug Tolerance; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Placebos; Psychomotor Agitation; Quinolones; United States

2009

Other Studies

1 other study(ies) available for aripiprazole and Dementia, Vascular

Article	Year
Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model. Behavioural brain research, 2019, 06-03, Volume: 365 Topics: Animals; Aripiprazole; Brain; Brain Ischemia; Carotid Stenosis; Cilostazol; Cognition; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Drug Therapy, Combination; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Spatial Learning	2019

Article

Year

Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model.

Behavioural brain research, 2019, 06-03, Volume: 365

Topics: Animals; Aripiprazole; Brain; Brain Ischemia; Carotid Stenosis; Cilostazol; Cognition; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Drug Therapy, Combination; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Spatial Learning

2019